Drug Stocks March 2026: Top 3 Picks for Growth and Safety
In March 2026, the drug stock landscape blends steady demand with ongoing innovation. This article highlights three c...
Learn smart investing strategies for stocks, ETFs, bonds, and building long-term wealth.
5,594 articlesIn March 2026, the drug stock landscape blends steady demand with ongoing innovation. This article highlights three c...
A wave of enthusiasm for AI infrastructure helped Tower Semiconductor leap higher this week. Investors spotlighted si...
Market volatility is back in March 2026, and defensive moves can help. This guide highlights three defensive ETFs wor...
As AI workloads demand more network performance, Arista Networks and Broadcom stand out. This guide breaks down their...
Geopolitical tensions surrounding Iran are rattling markets. In this environment, SPLG stands out as a low-cost ancho...
U.S. authorities charged the co-founder of Super Micro Computer and two associates in a $2.5 billion scheme to ship s...
Microvast’s Q4 2025 results trigger a sharp pullback in mvst stock down this year. A $32.5 million inventory impairme...
AppLovin posted stronger-than-expected Q4 results with robust margins and a strategic pivot to e-commerce ads, while ...
Epic Fury is spreading beyond energy prices, hitting travel, remittances, and food imports in Asia. The resulting pol...
Hess Midstream signals a major shift from expansion to cash returns, projecting $850-$900 million in adjusted free ca...
Gartner CEO Gene Hall tells investors the benefits from recent product and engagement upgrades will appear gradually ...
CF Industries has surged this year on supply constraints and cost advantages, yet a DOJ probe adds regulatory risk th...